InnovaQor Inkomsten in het verleden
Verleden criteriumcontroles 0/6
InnovaQor's earnings have been declining at an average annual rate of -76.8%, while the Healthcare Services industry saw earnings growing at 14% annually. Revenues have been growing at an average rate of 42.9% per year.
Belangrijke informatie
-76.8%
Groei van de winst
-70.4%
Groei van de winst per aandeel
Healthcare Services Groei van de industrie | 1.7% |
Inkomstengroei | 42.9% |
Rendement op eigen vermogen | n/a |
Nettomarge | -386.4% |
Laatste winstupdate | 30 Sep 2023 |
Recente prestatie-updates uit het verleden
Geen updates
Recent updates
Opbrengsten en kosten
Hoe InnovaQor geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Sep 23 | 1 | -2 | 2 | 0 |
30 Jun 23 | 1 | -2 | 2 | 0 |
31 Mar 23 | 0 | -2 | 1 | 0 |
31 Dec 22 | 0 | -2 | 1 | 0 |
30 Sep 22 | 0 | -1 | 1 | 0 |
30 Jun 22 | 0 | -1 | 1 | 0 |
31 Mar 22 | 0 | -1 | 1 | 0 |
31 Dec 21 | 0 | -1 | 1 | 0 |
31 Dec 20 | 1 | -1 | 1 | 0 |
Kwaliteitswinsten: INQR is currently unprofitable.
Groeiende winstmarge: INQR is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: Insufficient data to determine if INQR's year-on-year earnings growth rate was positive over the past 5 years.
Versnelling van de groei: Unable to compare INQR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: INQR is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (35.1%).
Rendement op eigen vermogen
Hoge ROE: INQR's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.